Topic: Promus
CHICAGO (Reuters) - U.S. health regulators said they are still investigating a rare but serious problem with Boston Scientific Corp's new heart stents and required the company to caution doctors about it when the device was approved last month.The Food and Drug ...
(Reuters) - Health regulators are investigating a rare but potentially serious problem with a newer class of heart stents that causes the tiny tubular devices made of wire mesh to shrink, or lengthen, after implantation.The problem appears to occur most frequently in ...
(Reuters) - Health regulators are investigating a rare but potentially serious problem with a newer class of heart stents that causes the tiny tubular devices made of wire mesh to shrink, or lengthen, after implantation.The problem appears to occur most frequently in ...
Boston Scientific Corporation (BSX) Investor Day Conference Call November 19, 2010 8:00 am ET. Boston Scientific and I'd just use DES here as the example, served market share in developed markets is 31% compared to 6% in emerging markets. Now Dr. Dawkins ...
